News Coverage - Parker Institute for Cancer Immunotherapy

Research
Network
News
About
Donate

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Donate

Endpoints

11.14.17

Parker Institute, MD Anderson and Seres developing a microbiome/PD-1/L1 combo

Read

Reuters Health

11.14.17

Biotech firms race to recruit good bugs in war on cancer

Read

STAT

11.14.17

Finding a way for the ‘right’ microbiome to help cancer immunotherapy work

Read

BioCentury Extra

11.14.17

Seres, MD Anderson, Parker In Microbiome Immunotherapy Deal

Read

SITC

11.11.17

Sean Parker awarded SITC 2017 Public Service Award

Read

MedPage Today

11.07.17

Does Gut Flora Impact the Response to Cancer Immunotherapy?

Read

Science Friday

11.03.17

How the Microbiome Can Affect Cancer Treatments

Read

Fortune

11.03.17

The Secret to Cancer Treatment May Be In Our Guts

Read

Bio-IT World

11.02.17

News From October 2017

Read

The Lancet Oncology

10.31.17

Future Research Priorities in the USA: a Lancet Oncology Commission

Read

Endpoints

10.19.17

Sean Parker’s cancer institute keeps growing with some “mind blowing” new research projects

Read

Popular Science

10.17.17

Body, heal thyself

Read